Prot# TVP-1012/500 (ADAGIO): A Multicenter, Double-Blind, Randomized Start, Placebo-Controlled, Parallel-Group Study to Assess Rasagiline as a Disease Modifying Therapy in Early Parkinson's Disease Subjects

Project: Research project

Project Details

StatusFinished
Effective start/end date12/22/056/16/09

Funding

  • Teva Neuroscience, Inc. (TVP-1012/500 (ADAGIO))